Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00039117 Information provided by National Cancer Institute (NCI)

First Received: June 6, 2002 Last Updated: April 4, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given